enGene Holdings Inc. - ENGN
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G | Cormorant Asset Management, LP | 5.97% | 4,000,000 | View |
| Feb 17, 2026 | SCHEDULE 13G | Bihua Chen | 5.97% | 4,000,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Kynam Capital Management, LP | 2.23% | 1,492,898 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Kynam Capital Management GP, LLC | 2.23% | 1,492,898 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Yue Tang | 2.23% | 1,492,898 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 7.1% | 4,771,414 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 7.1% | 4,771,414 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 7.1% | 4,771,414 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 7.1% | 4,771,414 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 7.1% | 4,771,414 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Nimish Shah | 7.1% | 4,771,414 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 7.1% | 4,771,414 | View |
| Jan 27, 2026 | SCHEDULE 13G | Invus Public Equities, L.P. | 5.5% | 3,675,408 | View |
| Jan 27, 2026 | SCHEDULE 13G | Invus Public Equities Advisors, LLC | 5.5% | 3,675,408 | View |
| Jan 27, 2026 | SCHEDULE 13G | Invus Global Management, LLC | 5.5% | 3,675,408 | View |
| Jan 27, 2026 | SCHEDULE 13G | Siren, L.L.C. | 5.5% | 3,675,408 | View |
| Jan 27, 2026 | SCHEDULE 13G | Avicenna Life Sci Master Fund LP | 0.8% | 569,151 | View |
| Jan 27, 2026 | SCHEDULE 13G | Avicenna Life Sci Master GP LLC | 0.8% | 569,151 | View |
| Jan 27, 2026 | SCHEDULE 13G | Ulys, L.L.C. | 0.8% | 569,151 | View |
| Jan 27, 2026 | SCHEDULE 13G | Raymond Debbane | 6.3% | 4,244,559 | View |
| Nov 18, 2025 | SCHEDULE 13G | Deep Track Capital, LP | 6.69% | 4,317,332 | View |
| Nov 18, 2025 | SCHEDULE 13G | Deep Track Biotechnology Master Fund, Ltd. | 6.69% | 4,317,332 | View |
| Nov 18, 2025 | SCHEDULE 13G | David Kroin | 6.69% | 4,317,332 | View |
| Nov 18, 2025 | SCHEDULE 13G | Perceptive Advisors LLC | 9.99% | 6,770,605 | View |
| Nov 18, 2025 | SCHEDULE 13G | Joseph Edelman | 9.99% | 6,770,605 | View |
| Nov 18, 2025 | SCHEDULE 13G | Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 6,770,605 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Capital, LP | 4.37% | 2,239,353 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 4.37% | 2,239,353 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | David Kroin | 4.37% | 2,239,353 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.